Novel long noncoding RNA LINC02323 promotes cell growth and migration of ovarian cancer via TGF‐β receptor 1 by miR‐1343‐3p
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel long noncoding RNA LINC02323 promotes cell growth and migration of ovarian cancer via TGF‐β receptor 1 by miR‐1343‐3p
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL LABORATORY ANALYSIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-11-28
DOI
10.1002/jcla.23651
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Unique metastasis‐associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma
- (2020) Xiaoshi Zhang et al. Thoracic Cancer
- Novel long non‐coding RNA LINC02323 promotes epithelial‐mesenchymal transition and metastasis via sponging miR ‐1343‐3p in lung adenocarcinoma
- (2020) Xiaoshi Zhang et al. Thoracic Cancer
- MAGI2‐AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR‐525‐5p/MXD1 axis
- (2020) Hua Chang et al. Cancer Medicine
- The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p
- (2020) Shuzhen Kong et al. EXPERIMENTAL CELL RESEARCH
- Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway
- (2019) Yi Guo et al. GYNECOLOGIC ONCOLOGY
- Identification of lncRNA–miRNA–mRNA regulatory network associated with epithelial ovarian cancer cisplatin‐resistant
- (2019) Xin Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cell Type-Specific TGF-β Mediated EMT in 3D and 2D Models and Its Reversal by TGF-β Receptor Kinase Inhibitor in Ovarian Cancer Cell Lines
- (2019) Wafa Al Ameri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- LncRNA DANCR promotes tumor growth and angiogenesis in ovarian cancer through direct targeting of miR‐145
- (2019) Xiaojuan Lin et al. MOLECULAR CARCINOGENESIS
- Avelumab (anti-PD-L1) in platinum-resistant/refractory ovarian cancer: JAVELIN Ovarian 200 Phase III study design
- (2018) Eric Pujade-Lauraine et al. Future Oncology
- The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes
- (2018) Na Li et al. GYNECOLOGIC ONCOLOGY
- TGF-β-mediated LEFTY/Akt/GSK-3β/Snail axis modulates epithelial-mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinomas
- (2018) Toshihide Matsumoto et al. MOLECULAR CARCINOGENESIS
- Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
- (2018) Willemien J. van Driel et al. NEW ENGLAND JOURNAL OF MEDICINE
- nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer
- (2018) Ji-Hye Ahn et al. Nature Communications
- LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression
- (2018) Haihai Liang et al. Molecular Cancer
- LncRNA LINC00319 accelerates ovarian cancer progression through miR-423-5p/NACC1 pathway
- (2018) Wenling Du et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
- (2016) Ian J Jacobs et al. LANCET
- TGF- Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment
- (2013) T.-L. Yeung et al. CANCER RESEARCH
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started